Marrone Bio Innovations, Inc. MBII

Full chart Compare
Set alert

Price alert · MBII

All alert types
0.80 0.00 (+0.00%)

Apr 24, 2025, 3:47 PM EDT

0.747 Day range 1.02

52-week range unavailable

Analyst view

Consensus: buy

Buy
Price target (mean) 1.38 +72.9% upside
Target (low)
0.90
Target (mean)
1.38
Target (high)
2.00
Ratings (0m) 1 0 buy · 1 hold · 0 sell
  • Strong buy0
  • Buy0
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 1
  • 1 month ago 4
  • 2 months ago 4
  • 3 months ago 2

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

MBII analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.04-0.04 – -0.04-0.02-100.0%16.00M+27.0%1
Next quarter-0.04-0.04 – -0.04-0.03-33.3%15.30M+43.9%1
Current year-0.10-0.15 – -0.06-0.09-11.1%56.45M+27.4%2
Next year-0.02-0.02 – -0.02-0.10+80.0%71.00M+25.8%2

Upgrades and downgrades

The latest rating changes

MBII analyst upgrades and downgrades
DateFirmActionFromTo
Sep 22, 2021Roth CapitalInitiated—Buy
Aug 19, 2021Aegis CapitalMaintained—Buy
Feb 11, 2021Aegis CapitalMaintained—Buy
Aug 14, 2020Aegis CapitalMaintained—Buy
Jul 28, 2020Canaccord GenuityInitiated—Buy
May 14, 2020Aegis CapitalMaintained—Buy
Nov 23, 2016JefferiesMaintained—Hold
Mar 16, 2016Rodman & RenshawInitiated—Buy
May 20, 2015JefferiesDowngradeBuyHold
Sep 4, 2014Stifel NicolausMaintained—Buy
Aug 8, 2014PiperJaffrayDowngradeOverweightNeutral
Aug 8, 2014BairdDowngradeOutperformNeutral
Jun 30, 2014BairdInitiated—Outperform
Jun 9, 2014JefferiesMaintained—Buy
Nov 11, 2013Stifel NicolausMaintained—Buy
Aug 27, 2013Stifel NicolausInitiated—Buy
Aug 27, 2013JefferiesInitiated—Buy
Aug 27, 2013PiperJaffrayInitiated—Overweight